A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency

Andrea Keyter ^1,2 , Sam Salek ¹ * , Shabir Banoo ^2,3, Stuart Walker ^4,1

Cited by CrossRef:

1- Moeti L, Litedu M, Joubert J. The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharm Med. 2023;37(1):71 [Crossref]

2- Keyter A, Salek S, Danks L, Nkambule P, Semete-Makokotlela B, Walker S. South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access. Front Pharmacol. 2021;12 [Crossref]

3- Matovu B, Takuwa M, Mpaata C, Denison F, Kiwanuka N, Lewis S, Norrie J, Ononge S, Muhimbise O, Tuck S, Etuket M, Ssekitoleko R. Review of investigational medical devices' clinical trials and regulations in Africa as a benchmark for new innovations. Front Med Technol. 2022;4 [Crossref]

Submit Your Paper Archive